Overview

A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome

Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of angiotensin II receptor blocker, Losartan, to prevent progressive dilation of aortic root in patients with Marfan syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Atenolol
Losartan
Propranolol